Insider Transactions
| Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 25, 2019 | Chief Medical Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 43,730 | $12.52 | 129,767 | |
| Feb 25, 2019 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 26,270 | -- | 68,730 | |
| Feb 25, 2019 | Chief Medical Officer | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 43,730 | -- | 6,270 | |
| Feb 19, 2019 | Ten Percent Owner | Other acquisition or disposition | Form 4 | -- | -- | 20,724,424 | |
| Feb 05, 2019 | Director, Chairman & CEO | Other acquisition or disposition | Form 4 | -- | -- | 64,895 | |
| Feb 01, 2019 | Director, Chairman & CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 20,000 | $3.82 | 688,081 | |
| Feb 01, 2019 | Director, Chairman & CEO | Open market or private sale of non-derivative or derivative security | Form 4 | 20,000 | $12.12 | 668,081 | |
| Feb 01, 2019 | Director, Chairman & CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 20,000 | -- | 210,000 | |
| Jan 29, 2019 | Chief Medical Officer | Other acquisition or disposition | Form 4 | -- | -- | 129,767 | |
| Jan 25, 2019 | Chief Medical Officer | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | Form 4 | 94 | -- | 31 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.